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Imported malaria
Malaria remains a major cause of morbidity and mortality, 
with its greatest toll on populations in sub-Saharan Africa, 
where it impedes economic development. The World Health 
Organization estimated that there were over 800 000 malaria 
deaths in Africa in 2006, 85% of them in children <5 years 
of age. The increase in case-fatality rates in recent years is 
attributed largely to increasing resistance to antimalarial drugs 
in Plasmodium spp. Effective malarial control for over 50 years 
in South Africa has resulted in the risk of malaria being low, 
seasonal and limited to the low-lying north-eastern areas of the 
country. Because of the decline in cases nationally, patients and 
health care workers, particularly in malaria-free areas, may be 
less likely to suspect or recognise malaria. While artemisinin 
combination therapy (ACT) for uncomplicated malaria and 
quinine for severe or complicated malaria form part of the 
national policy in malaria-risk areas in South Africa, ACT is not 
available in the public sector outside these areas, and common 
practice is to administer a 7-day course of quinine treatment.
Weber and colleagues conducted a prospective survey 
of malaria cases diagnosed in hospitals in Gauteng from 
December 2005 to end November 2006 to describe the burden 
of malaria and identify potential risk factors for severe disease.1
Participants from 47 health care facilities submitted 
questionnaires on 1 701 malaria cases; 91% were seen at public 
sector hospitals and 9% at private sector hospitals, dispelling 
the notion that imported malaria is confined to affluent 
recreational travellers. Males accounted for 68% of patients, 
consistent with labour-related migration between malaria-
endemic areas and Gauteng. Among males and females 
there were peaks in children aged under 10 years and adults 
aged 20 - 49 years. The majority of malaria cases occurred in 
the summer months, with a peak in January. The presumed 
geographical regions where the infection was acquired were 
Mozambique (84%), malaria-risk parts of South Africa (10%), 
and other African countries and south-east Asia (<1% each).
Apart from preventive measures and, when indicated, 
malaria chemoprophylaxis, the authors recommend that 
national and provincial health departments should consider 
changing treatment policy from quinine to ACT for treating 
patients with uncomplicated malaria at public sector facilities 
in non-malaria provinces.
Caesarean section – local anaesthetic 
pain relief 
Delivery by caesarean section (CS) is becoming more frequent 
and is one of the most common major operative procedures 
performed worldwide. CS rates are 20 - 26% in the USA, 
Canada and the UK, while in the private sector in South Africa 
the rate is >50%. CS is performed under spinal anaesthesia, 
spinal epidural, epidural block or general anaesthesia. Because 
childbirth is an emotion-filled event and the mother needs 
to bond with her baby as soon as possible, any intervention 
that leads to pain relief is worthy of investigation. The review 
by Bamigboye and Hofmeyr2 assessed the effects of local 
anaesthetic agent wound infiltration and/or abdominal nerve 
blocks on pain after CS and the mother’s well-being and 
interaction with her baby.
Their review found that women undergoing CS under 
regional analgesia who had local anaesthetic infiltration or 
abdominal nerve block had a reduced need for postoperative 
opioids. 
Dosage adjustment in patients with 
renal impairment
In patients with renal impairment, doses of renally excreted 
drugs should be adjusted. Failure to do so may lead to adverse 
effects, including nephrotoxicity. The incidence of in-hospital 
acute kidney injury attributed to drug nephrotoxicity is 
estimated at 19%. 
The experience of dosage adjustment in medical patients 
with renal impairment at Groote Schuur Hospital was 
reviewed by Decloedt and colleagues.3 They found renal 
impairment in 32% of medical admissions. Dosage adjustment 
was required in 19% of prescription entries, and only 32% 
of these were correctly adjusted. Their finding that drug 
dose adjustment was frequently neglected is consistent with 
international studies. Strategies to alert clinicians to the need 
for dose adjustment in renal impairment should be considered, 
including automated eGFR reporting and computerised aids to 
guide drug dosing, which account for renal impairment.
Acute viral bronchiolitis guideline
Bronchiolitis most commonly occurs as an acute illness in 
children younger than 2 years of age. The most frequent 
cause is rhinovirus or respiratory syncytial virus infection. In 
a guideline endorsed by the South African Thoracic Society, 
Green and colleagues4 review the causative organisms, 
seasonality, clinical manifestations and diagnosis, features of 
severe disease, management, prevention and patient education. 
Principles regarding bronchiolitis that should be explained to 
parents or caregivers include that the condition is generally not 
serious, most cases do not require medication, antibiotics are 
of no value, respiratory symptoms should be monitored and 
concerns reported to their doctor, and symptoms may continue 
for weeks. 
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